Shanghai Haohai Biological Technology Co., Ltd. (6826.HK) HKSE

27.26

+0.08(+0.29%)

Updated at December 05 11:58AM

Currency In HKD

Valuation

Market Cap5.83B
Enterprise Value3.65B
P/E Ratio28.82
PEG Ratio-12.32
Price/Sales Ratio3.69
Price/Book Ratio1.97
Enterprise/Revenue2.86
Enterprise/EBITDA15.15

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.15
Operating Margin-0.04

Management Effectiveness

Return On Assets0.05
Return On Equity0.07

Income Statement

Revenue2.68B
Revenue/Share10.95
Gross Profit1.87B
EBITDA549.05M
Net Income420.45M
Diluted EPS1.8

Balance Sheet

Total Cash2.66B
Total Cash/Share11.39
Total Debt439.77M
Total Debt/Equity0.07
Current Ratio3.77
Book Value Per Share25.8

Price History

52-Week Change-1.88
52-Week High34.35
52-Week Low21.7
Moving Average 50 Days27.12
Moving Average 200 Days26.87

Statistics

Average Volume259,731
Shares Outstanding410.46M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1
Trailing Annual Dividend Yield2.06
Payout Ratio0.89
Last Split Factor7:5
Last Split DateJune 06, 2024